Clinical Trial Update: Evaluation of the Performances of the Sleep Disordered Breathing Monitoring Function in Pacemaker [Phase 3]

View source ↗

Summary

A Phase 3 trial by LivaNova evaluating the performance of the Sleep Disordered Breathing Monitoring function in a pacemaker for patients with bradycardia. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bradycardia

Drugs mentioned

• LivaNova Sleep Disordered Breathing Monitoring Pacemaker

Snippet

Sponsor: LivaNova | Conditions: Bradycardia | Phase 3 | Status: COMPLETED